WI Harper Group-backed AEONMED and Resvent Medical’s ventilators battle against COVID-19 in Europe

WI Harper Group | 2020-03-24 The world is united in battle against the coronavirus. Two companies backed by WI Harper Group, AEONMED and Resvent Medical, have entered the European market with ventilators. They are working with international companies in the global fight against the pandemic.  | AEONMED Medical joins Chinese consortium to aid Italy The…

WI Harper-backed Avaamo releases Project COVID, a publicly accessible and interactive COVID-19 Intelligent Virtual Assistant

WI Harper Group | 2020-03-24     Article Source: Avaamo Avaamo is an enterprise software company. Avaamo’s bot platform uniquely combines natural language processing, Artificial Intelligence (AI) and Machine Learning technologies to enable enterprises to create, develop, manage and rapidly deploy enterprise chatbots for use by employees and customers. The Project COVID was launched by Avaamo in order…

The China FOF Alliance recognizes WI Harper Group as “Advanced Collective of Chinese Equity Investment Institutions in the Battle Against Novel Coronavirus”

WI Harper Group | 2020-03-09 On March 8th, the 2020 China Equity Investment Industry Conference was held in the form of online live broadcasting with support from China Venture Capital Co., the China FOF Alliance, and the China FOF Research Institute. The conference acknowledged and awarded WI Harper Group the Advanced Collective of Chinese Equity…

WI Harper Group’s Portfolio companies help on novel coronavirus nucleic acid testing, drug development, and medical equipment to fight the pandemic

WI Harper Group | 2020-03-04 We continue to see many of WI Harper Group backed companies on the front lines of the battle against coronavirus since the outbreak. For example, the electrocardiograph of Edan Instruments, the ventilators other medical equipment from Resvent Medical and Aeonmed, and the ICU System of MedicalSystem Technology have been put…

WI Harper Group-backed Amwise Diagnostics closes Series B round, achieving accurate prognosis assessment of breast cancer in Asia

WI Harper Group| 2020-02-29 The following article comes from 动脉新医药 Author 徐文娟 Recently, WI Harper-backed Amwise Diagnostics,successfully completed the first close of its B round financing. This financing is led by Jiangsu Simcere Pharmaceutical Co., Ltd, a subsidiary of SimcereHoldings. The funds raised will mainly be used to promote the comprehensive upgrade of the Asian Breast…